EFFECTIVENESS OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN PREVENTING HOSPITALISATION DUE TO PNEUMONIA IN OLDER PERSONS
Funder
National Health and Medical Research Council
Funding Amount
$258,475.00
Summary
Flu and pneumococcus remain important causes of illness and death in Australia. They can cause pneumonia and severe respiratory illness, including death, especially in older people. This is because natural immunity against infections tends to decrease with age. Vaccination against flu and pneumococcus is therefore recommended for all persons aged 65 years or older, but only in Victoria are both vaccines publicly funded. The Victorian initiative appears to have had a marked impact on improving va ....Flu and pneumococcus remain important causes of illness and death in Australia. They can cause pneumonia and severe respiratory illness, including death, especially in older people. This is because natural immunity against infections tends to decrease with age. Vaccination against flu and pneumococcus is therefore recommended for all persons aged 65 years or older, but only in Victoria are both vaccines publicly funded. The Victorian initiative appears to have had a marked impact on improving vaccination coverage, but its impact on disease has never been assessed. This study will estimate vaccination coverage, missed vaccination opportunities, effectiveness of flu and pneumococcal vaccines in preventing hospitalisation for pneumonia, and cost-effectiveness of the currently funded vaccination program in this age group. This is considered a priority because of the serious but preventable nature of the diseases caused by these infections. This study will improve awareness of the importance of vaccination among individuals, and given the high estimated vaccine coverage in older Victorians, is well placed to provide the first available evidence for or against effectiveness and cost-effectiveness of flu and pneumococcal vaccination in older Australians. The results may have major implications for public health policy in Victoria and elsewhere in Australia.Read moreRead less
Systematic Practice-based Asthma Care In The Australian Setting
Funder
National Health and Medical Research Council
Funding Amount
$563,625.00
Summary
Asthma is an illness which increasingly is affecting the health and quality of life of millions of Australians. Much effort has been focused in recent years on ways of improving the management of those people who suffer from moderate and severe asthma. A recent government initiative has been to promote the use of the 3+ Visit Plan, which encourages a more proactive, systematic approach to assessing and treating asthma in general practice. There is currently no evidence about exactly how practice ....Asthma is an illness which increasingly is affecting the health and quality of life of millions of Australians. Much effort has been focused in recent years on ways of improving the management of those people who suffer from moderate and severe asthma. A recent government initiative has been to promote the use of the 3+ Visit Plan, which encourages a more proactive, systematic approach to assessing and treating asthma in general practice. There is currently no evidence about exactly how practices can best be organized to provide this systematic care, in a way which improves the process of care and the health outcomes for patients. This study aims to evaluate the effectiveness of changing aspects of practice organization and structure, such as setting up registers of asthma patients, providing recalls or reminders to patients to come in for regular review, having the GPs provide education and self-management skills to patients, focusing on the contributions which practice staff can make to the process, and initiating quality assurance measures such as audit and feedback to the GPs about their quality of care. We anticipate that these changes will provide positive benefits for the patients, but will also investigate what it costs the practices, patients and government to bring these changes about, within the perspective of efficiency and cost-effectiveness. The evidence generated by this study will provide an excellent base for providing advice to policy makers, as well as contributing to the development of best-practice models of care for asthma patients in general practice.Read moreRead less
Mass Disseminable Approaches To Smoking Cessation In General Practice
Funder
National Health and Medical Research Council
Funding Amount
$412,100.00
Summary
Tobacco smoking is the most significant preventable cause of mortality in Australia. At any one time, many smokers want to quit. There are several interventions that are known to work in research settings, such as advice from care providers, self-help materials, drug therapies and telephone counselling. This study wants to find out if these strategies work in ordinary general practice. Over 50% of Australian have access to the Internet and research suggests that seeking health information is one ....Tobacco smoking is the most significant preventable cause of mortality in Australia. At any one time, many smokers want to quit. There are several interventions that are known to work in research settings, such as advice from care providers, self-help materials, drug therapies and telephone counselling. This study wants to find out if these strategies work in ordinary general practice. Over 50% of Australian have access to the Internet and research suggests that seeking health information is one of the most common uses of this technology. The rapid growth of Internet use potentially provides access to a number of cessation aids for tobacco smokers, including online support through 'chat rooms'. It is also possible to tailor interventions to individuals according to their stated interests and readiness to quit. General practitioners, in addition to providing support and care to smokers attemtping to quit, can direct them to community services such as Quit Victoria, which now offers smoking cessation programs tailored to individuals' needs delivered either through telephone counselling or by the Internet. We want to know whether more smokers quit successfully if their GP refers them to Quit services in addition to their usual care. As well as assessing the effectiveness of broadly distributable interventions in smoking cessation, this project will also collect data about the use of the Internet for health research. Little is known about how to perform research on the Web. This project will allow automatic monitoring of how people respond to research endeavours in this environment.Read moreRead less
Exercise Therapy For Prevention Of Falls In People With Parkinsons Disease: A Randomised Controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$598,820.00
Summary
Despite optimal medication regimes, people with Parkinson's disease frequently and recurrently experience falls. Up to 68% of the 100,000 people living in Australia with Parkinson's disease fall every year and fall-related injuries are the most common reason why people with Parkinson's disease are admitted to hospital. This project will implement an exercise program targeting risk factors for falls and will determine the efficacy and the cost effectiveness of the program.
Development And Validation Of An Australian Diabetes Health Policy Simulation Model
Funder
National Health and Medical Research Council
Funding Amount
$400,396.00
Summary
Diabetes imposes a heavy personal, societal and financial burden on Australia and this is predicted to increase over time. The aim of this project is to develop a computer simulation model that can be used to inform clinicians and policy makers in efficient allocation of resources to improve the quality of diabetes care.
ACTIVE Dialysis: A Clinical Trial Of IntensiVE Dialysis
Funder
National Health and Medical Research Council
Funding Amount
$1,310,836.00
Summary
People with kidney disease requiring dialysis have substantially reduced life expectancy, poorer health status and quality of life. Better treatments are therefore urgently required. ACTIVE Dialysis is a clinical trial that will assess whether increased duration of dialysis improves these critical outcomes. A formal cost-effectiveness analysis will be conducted from a health system perspective.